联合肿瘤标志物与常规超声及超声造影特征鉴别胃肠道间质瘤肝转移与结直肠癌肝转移
回顾性纳入80例病理证实的胃肠道间质瘤肝转移(GISTLM)与80例结直肠癌肝转移(CRCLM)患者,分析CA125、CEA及常规超声和超声造影特征。多因素分析显示CA125升高、CEA正常、低或混合回声、无回声区、包膜增强、廓清开始时间>40秒、无增强区比例>20%为GISTLM独立特征;联合肿瘤标志物与影像特征后诊断敏感度从36.3-57.5%提高至70.0%,AUROC从0.681-0.750提高至0.838,特异度97.5%。
要点
- CA125升高且CEA正常提示GISTLM可能。
- 常规超声低或混合回声、无回声区与GISTLM相关。
- 超声造影包膜增强、廓清开始时间>40秒、无增强区比例>20%提示GISTLM。
关键影像表现/征象
- 常规超声上,低回声或混合回声及无回声区与GISTLM相关。
- 超声造影上,包膜增强、廓清开始时间>40秒、无增强区比例>20%为提示GISTLM的特征。
- 以上特征P值均<0.05。
诊断标准与关键数值
- 多因素logistic回归显示CA125升高和CEA正常为GISTLM的独立变量。
- 联合肿瘤标志物与影像特征诊断GISTLM的敏感度为70.0%,特异度为97.5%,AUROC为0.838。
- 单独影像特征诊断GISTLM的敏感度为36.3-57.5%,AUROC为0.681-0.750。
临床应用与阅片要点
- 阅片时关注常规超声低或混合回声、无回声区,以及超声造影包膜增强、廓清开始时间>40秒、无增强区比例>20%。
- 结合血清CA125升高和CEA正常可提高鉴别GISTLM与CRCLM的诊断效能。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To explore the value of tumor marker CA125 and CEA linked with conventional ultrasound (US) and contrast-enhanced ultrasound (CEUS) features in differentiating gastrointestinal stromal tumors liver metastases (GISTLM) from colorectal cancer liver metastases (CRCLM).
MATERIALS AND METHODS: From December 2005 to February 2019, eighty patients with pathologically proven GISTLM together with 80 CRCLM patients were retrospectively evaluated with contrast-enhanced ultrasound (CEUS). Clinical characteristics such as CA125 and CEA were documented to compare the difference between GISTLM and CRCLM. Univariate analysis was performed to determine significant features in ultrasound and then these features were entered into multivariate logistic regression model to determine diagnostic criteria. By analyzing the tumor marker and imaging features, diagnostic performance was evaluated via receiver-operating characteristic (ROC) analysis. The sensitivity, specificity and accuracy were calculated for the diagnosis of GISTLM.
RESULTS: Multiple logistic regression analysis showed that increased CA125 and normal CEA were the independent variables of GISTLM. On conventional US, the features of hypo- or mix-echogenicity and anechoic area were associated with GISTLM. On CEUS, capsule enhancement, starting time of washout > 40 s and proportion of non-enhancement area > 20% were the features indicating GISTLM. All of the p values were < 0.05. When linking tumor marker with imaging features, the diagnostic sensitivity improved from 36.3-57.5% to 70.0%, and the area under the ROC (AUROC) curve improved from 0.681-0.750 to 0.838, with a specificity of 97.5%.
CONCLUSIONS: Combining the imaging features of conventional US and CEUS with serum tumor markers provides a potentially effective diagnostic method in differentiation of GISTLM and CRCLM.
引用
- Yang D, Zhuang B, Wang W, et al. Differential diagnosis of liver metastases of gastrointestinal stromal tumors from colorectal cancer based on combined tumor biomarker with features of conventional ultrasound and contrast-enhanced ultrasound. Abdom Radiol (NY). 2020. PMID: 32458028. doi:10.1007/s00261-020-02592-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。